X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.prnewswire.com/news-releases/abbvie-announces-late-breaking-data-at-aan-supporting-long-term-safety-and-efficacy-of-atogepant-qulipta-for-preventive-treatment-of-migraine-302114992.html
https://news.abbvie.com/news/press-releases/abbvie-announces-european-commission-approval-aquipta-atogepant-for-preventive-treatment-migraine-in-adults.htm?_ga=2.178894180.1995306136.1692275398-1940551860.1689837609
https://endpts.com/chmp-recommends-abbvies-migraine-drug-gsks-anemia-treatment/
https://www.pharmatimes.com/news/abbvie_reveals_results_from_pivotal_atogepant_trial_1490877
https://endpts.com/abbvies-qulipta-adds-fda-approval-for-chronic-migraine/
https://news.abbvie.com/news/press-releases/us-fda-approves-qulipta-atogepant-for-adults-with-chronic-migraine.htm
https://www.prnewswire.com/news-releases/at-fifteen-months-post-launch-abbvies-qulipta-outperforms-pfizers-nurtec-odt-on-perceived-overall-efficacy-in-the-preventive-migraine-space-according-to-spherix-global-insights-301774530.html
https://www.prnewswire.com/news-releases/abbvie-submits-marketing-authorization-application-to-ema-for-atogepant-for-the-preventive-treatment-of-migraine-301587831.html
https://news.abbvie.com/news/press-releases/abbvie-submits-supplemental-new-drug-application-to-us-fda-for-atogepant-qulipta-to-support-label-expansion-for-preventive-treatment-migraine.htm
https://www.biospace.com/article/abbvie-prepares-to-seek-supplemental-approval-for-migraine-treatment/
https://www.fiercepharma.com/pharma/abbvie-pressures-biohaven-migraine-prevention-fda-approval-for-cgrp-blockbuster-to-be
https://www.fiercebiotech.com/biotech/migraine-market-better-make-way-for-abbvie-as-oral-preventative-treatment-atogepant-poised
Market Place
Share 
